Thrombotic and bleeding events after coronary stenting according to clopidogrel and aspirin platelet reactivity: VerifyNow French Registry (VERIFRENCHY)

Archives of Cardiovascular Diseases

Volumn 107, Issue 4, 2014, Pages 225-235

  Rangé, Grégoire ^a   Yayehd, Komlavi ^b   Belle, Loic ^b   Thuaire, Christophe ^a   Richard, Pascal ^c   Cazaux, Pierre ^d   Barbou, Franck ^e   Köning, René ^f   Chassaing, Stephan ^g   Teiger, Emmanuel ^h   Berthier, Romain ⁱ   Decomis, Marie Pascale ^j   Claudel, Jean Philippe ^k   Delarche, Nicolas ^l   Brunel, Philippe ^m   De Poli, Fabien ⁿ   Dupouy, Patrick ^o   Beygui, Farzin ^p   Albert, Franck ^a   Collet, Jean Philippe ^p   Montalescot, Gilles ^p   more..

^a Les Hopitaux de Chartres   (France)

^b Centre Hospitalier de la Region d'Annecy   (France)

^c Clinique Saint Martin   (France)

^d Centre Hospitalier de Lorient   (France)

^e University of Paris Descartes   (France)

^f Clinique Saint Hilaire   (France)

^g Clinique Saint Gatien   (France)

^h HENRI MONDOR HOSPITAL   (France)

ⁱ Service d'Endocrinologie et de Diabétologie   (France)

^j Clinique de la Reine Blanche   (France)

^k Infirmerie Protestante   (France)

^l Hôpital Pau   (France)

^m Nouvelles Cliniques Nantaises   (France)

ⁿ Centre Hospitalier de Haguenau   (France)

^o Hôpital Privé d'Antony   (France)

^p PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

more..

Author keywords

Bleeding; Ischaemic events; On platelet reactivity; VerifyNow assay

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST; ANTITHROMBOCYTIC AGENT; TICLOPIDINE;

AGED; ARTICLE; BARE METAL STENT; CARDIOVASCULAR MORTALITY; CONTROLLED STUDY; CORONARY STENT; CREATININE CLEARANCE; DRUG ELUTING STENT; DRUG SAFETY; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; INTERMEDIATE RISK POPULATION; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NON ST SEGMENT ELEVATION ACUTE CORONARY SYNDROME; OBSERVATIONAL STUDY; ON ASPIRIN PLATELET REACTIVITY; ON CLOPIDOGREL PLATELET REACTIVITY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PLATELET REACTIVITY; PROGNOSIS; PROSPECTIVE STUDY; STABLE ANGINA PECTORIS; STENT THROMBOSIS; THROMBOCYTE FUNCTION ANALYZER; TREATMENT RESPONSE; UNSTABLE ANGINA PECTORIS; ANALOGS AND DERIVATIVES; BLEEDING; BLOOD CLOTTING PARAMETERS; CHEMICALLY INDUCED; CLINICAL TRIAL; CORONARY THROMBOSIS; DRUG COMBINATION; FRANCE; MIDDLE AGED; MORTALITY; MYOCARDIAL INFARCTION; PREDICTIVE VALUE; REGISTER; RISK FACTOR; STENT; TREATMENT OUTCOME;

AGED; ASPIRIN; CORONARY THROMBOSIS; DRUG THERAPY, COMBINATION; FEMALE; FRANCE; HEMORRHAGE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PLATELET AGGREGATION INHIBITORS; PLATELET FUNCTION TESTS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; REGISTRIES; RISK FACTORS; STENTS; TICLOPIDINE; TREATMENT OUTCOME;

EID: 84901846801     PISSN: 18752136     EISSN: 18752128     Source Type: Journal    
DOI: 10.1016/j.acvd.2014.03.004     Document Type: Article

References (33)

1. W. Wijns, P. Kolh, and N. Danchin et al. Guidelines on myocardial revascularization Eur Heart J 31 2010 2501 2555
2. G. Esposito Responsiveness to P2Y12 receptor inhibitors Curr Opin Cardiol 26 Suppl. 1 2011 S31 S37
3. C. Godino, L. Mendolicchio, and F. Figini et al. Comparison of VerifyNow-P2Y12 test and flow cytometry for monitoring individual platelet response to clopidogrel. What is the cut-off value for identifying patients who are low responders to clopidogrel therapy? Thromb J 7 2009 4
4. N. Sambu, and N. Curzen Monitoring the effectiveness of antiplatelet therapy: opportunities and limitations Br J Clin Pharmacol 72 2011 683 696
5. K.J. Smock, P.J. Saunders, G.M. Rodgers, and V. Johari Laboratory evaluation of clopidogrel responsiveness by platelet function and genetic methods Am J Hematol 86 2011 1032 1034
6. J. Jang, J. Lim, and K. Chang et al. A comparison of INNOVANCE(R) PFA P2Y and VerifyNow P2Y12 assay for the assessment of clopidogrel resistance in patients undergoing percutaneous coronary intervention J Clin Lab Anal 26 2012 262 266
7. M. Valgimigli, G. Campo, and N. de Cesare et al. Intensifying platelet inhibition with tirofiban in poor responders to aspirin, clopidogrel, or both agents undergoing elective coronary intervention: results from the double-blind, prospective, randomized tailoring treatment with tirofiban in patients showing resistance to aspirin and/or resistance to clopidogrel study Circulation 119 2009 3215 3222
8. M. Valgimigli, G. Campo, and N. de Cesare et al. Tailoring treatment with tirofiban in patients showing resistance to aspirin and/or resistance to clopidogrel (3T/2R). Rationale for the study and protocol design Cardiovasc Drugs Ther 22 2008 313 320
9. H.J. Bouman, E. Parlak, and J.W. van Werkum et al. Which platelet function test is suitable to monitor clopidogrel responsiveness? A pharmacokinetic analysis on the active metabolite of clopidogrel J Thromb Haemost 8 2010 482 488
10. K. Thygesen, J.S. Alpert, and H.D. White Universal definition of myocardial infarction Eur Heart J 28 2007 2525 2538
11. D.E. Cutlip, S. Windecker, and R. Mehran et al. Clinical end points in coronary stent trials: a case for standardized definitions Circulation 115 2007 2344 2351
12. S. Schulman, and C. Kearon Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients J Thromb Haemost 3 2005 692 694
13. J. Daemen, P. Wenaweser, and K. Tsuchida et al. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study Lancet 369 2007 667 678
14. T. Gremmel, S. Steiner, and D. Seidinger et al. Comparison of methods to evaluate clopidogrel-mediated platelet inhibition after percutaneous intervention with stent implantation Thromb Haemost 101 2009 333 339
15. M. Lordkipanidze, C. Pharand, and T.A. Nguyen et al. Comparison of four tests to assess inhibition of platelet function by clopidogrel in stable coronary artery disease patients Eur Heart J 29 2008 2877 2885
16. N.J. Breet, J.W. van Werkum, and H.J. Bouman et al. Comparison of platelet function tests in predicting clinical outcome in patients undergoing coronary stent implantation JAMA 303 2010 754 762
17. G. Campo, L. Fileti, and N. de Cesare et al. Long-term clinical outcome based on aspirin and clopidogrel responsiveness status after elective percutaneous coronary intervention: a 3T/2R (tailoring treatment with tirofiban in patients showing resistance to aspirin and/or resistance to clopidogrel) trial substudy J Am Coll Cardiol 56 2010 1447 1455
18. R. Marcucci, A.M. Gori, and R. Paniccia et al. Cardiovascular death and nonfatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting are predicted by residual platelet reactivity to ADP detected by a point-of-care assay: a 12-month follow-up Circulation 119 2009 237 242
19. G. Patti, A. Nusca, and F. Mangiacapra et al. Point-of-care measurement of clopidogrel responsiveness predicts clinical outcome in patients undergoing percutaneous coronary intervention results of the ARMYDA-PRO (antiplatelet therapy for reduction of myocardial damage during angioplasty-platelet reactivity predicts outcome) study J Am Coll Cardiol 52 2008 1128 1133
20. M.J. Price, S. Endemann, and R.R. Gollapudi et al. Prognostic significance of post-clopidogrel platelet reactivity assessed by a point-of-care assay on thrombotic events after drug-eluting stent implantation Eur Heart J 29 2008 992 1000
21. J.W. Suh, S.P. Lee, and K.W. Park et al. Multicenter randomized trial evaluating the efficacy of cilostazol on ischemic vascular complications after drug-eluting stent implantation for coronary heart disease: results of the CILON-T (influence of cilostazol-based triple antiplatelet therapy on ischemic complication after drug-eluting stent implantation) trial J Am Coll Cardiol 57 2011 280 289
22. S.S. Brar, J. ten Berg, and R. Marcucci et al. Impact of platelet reactivity on clinical outcomes after percutaneous coronary intervention. A collaborative meta-analysis of individual participant data J Am Coll Cardiol 58 2011 1945 1954
23. J.P. Collet, T. Cuisset, and G. Range et al. Bedside monitoring to adjust antiplatelet therapy for coronary stenting N Engl J Med 2012
24. M.J. Price, P.B. Berger, and P.S. Teirstein et al. Standard- vs. high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial JAMA 305 2011 1097 1105
25. D. Trenk, G.W. Stone, and M. Gawaz et al. A randomized trial of prasugrel versus clopidogrel in patients with high platelet reactivity on clopidogrel after elective percutaneous coronary intervention with implantation of drug-eluting stents: results of the TRIGGER-PCI (testing platelet reactivity in patients undergoing elective stent placement on clopidogrel to guide alternative therapy with prasugrel) study J Am Coll Cardiol 59 2012 2159 2164
26. P.A. Gurbel, D. Erlinge, and E.M. Ohman et al. Platelet function during extended prasugrel and clopidogrel therapy for patients with ACS treated without revascularization: the TRILOGY ACS platelet function substudy JAMA 308 2012 1785 1790
27. S. Cook, and S. Windecker Early stent thrombosis: past, present, and future Circulation 119 2009 657 659
28. G.W. Stone, B. Witzenbichler, and G. Weisz et al. Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study Lancet 382 2013 614 623
29. S.R. Mehta, J.F. Tanguay, and J.W. Eikelboom et al. Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial Lancet 376 2010 1233 1240
30. T. Cuisset, G. Cayla, and C. Frere et al. Predictive value of post-treatment platelet reactivity for occurrence of post-discharge bleeding after non-ST elevation acute coronary syndrome. Shifting from antiplatelet resistance to bleeding risk assessment? EuroIntervention 5 2009 325 329
31. S.S. Jolly, S. Amlani, M. Hamon, S. Yusuf, and S.R. Mehta Radial versus femoral access for coronary angiography or intervention and the impact on major bleeding and ischemic events: a systematic review and meta-analysis of randomized trials Am Heart J 157 2009 132 140
32. G. Montalescot, G. Sideris, and C. Meuleman et al. A randomized comparison of high clopidogrel loading doses in patients with non-ST-segment elevation acute coronary syndromes: the ALBION (assessment of the best loading dose of clopidogrel to blunt platelet activation, inflammation and ongoing necrosis) trial J Am Coll Cardiol 48 2006 931 938
33. G. Campo, G. Parrinello, and P. Ferraresi et al. Prospective evaluation of on-clopidogrel platelet reactivity over time in patients treated with percutaneous coronary intervention relationship with gene polymorphisms and clinical outcome J Am Coll Cardiol 57 2011 2474 2483